Clinical Studies

Clinical Studies

 

IMPORTANT FACTS: The BeAT Heart Failure Study evaluates an investigational implantable device and has been approved and designated as an Expedited Access Pathway (EAP) program due to its potential as a therapy to treat a life-threatening disease with no approved alternative treatment.

Click here to check if you may qualify for the BeAT Heart Failure study

Click here to see the FDA approval and EAP designation letters

For more information on the FDA EAP process go to: https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/HowtoMarketYourDevice/ucm441467.htm